Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures.
Pacchioni A, Ferro J, Pesarini G, Mantovani R, Mugnolo A, Bellamoli M, Penzo C, Marchese G, Benedetto D, Turri R, Fede A, Benfari G, Saccà S, Ribichini F, Versaci F, Reimers B. Pacchioni A, et al. Among authors: pesarini g. Circ Cardiovasc Interv. 2019 Sep;12(9):e008045. doi: 10.1161/CIRCINTERVENTIONS.119.008045. Epub 2019 Sep 13. Circ Cardiovasc Interv. 2019. PMID: 31514524
Recurrent very late drug-eluting stent thrombosis.
Pesarini G, Arieti M, Spadaro R, Vassanelli C, Ribichini F. Pesarini G, et al. Cardiovasc Revasc Med. 2009 Apr-Jun;10(2):130-5. doi: 10.1016/j.carrev.2008.06.005. Cardiovasc Revasc Med. 2009. PMID: 19327678
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F, Tomai F, De Luca G, Boccuzzi G, Presbitero P, Pesarini G, Ferrero V, Ghini AS, Pastori F, De Luca L, Zavalloni D, Soregaroli D, Garbo R, Franchi E, Marino P, Minelli M, Vassanelli C. Ribichini F, et al. Among authors: pesarini g. J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):192-9. doi: 10.2459/JCM.0b013e32831f9176. J Cardiovasc Med (Hagerstown). 2009. PMID: 19377384 Clinical Trial.
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial.
Ribichini F, Ansalone G, Bartorelli A, Beqaraj F, Berni A, Colangelo S, D'Amico M, Della Rovere F, Fiscella A, Gabrielli G, Indolfi C, La Vecchia L, Loschiavo P, Marinoni G, Marzocchi A, Milazzo D, Romano M, Sangiorgio P, Sheiban I, Tamburino C, Tuccillo B, Villani R, Cappi B, Quijada MJ, Vassanelli C; EXECUTIVE Trial Investigators. Ribichini F, et al. J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):299-309. doi: 10.2459/JCM.0b013e3283331e69. J Cardiovasc Med (Hagerstown). 2010. PMID: 20090550 Clinical Trial.
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS).
Ribichini F, Tomai F, Reimers B, Russo P, Borioni R, Spartà D, Pacchioni A, Pesarini G, Spagnolo B, De Persio G, Cremonesi A, Castriota F. Ribichini F, et al. Among authors: pesarini g. EuroIntervention. 2010 Aug;6(3):328-35. doi: 10.4244/EIJV6I3A55. EuroIntervention. 2010. PMID: 20884410
106 results